Due to the growth in incidence of arthroplasty for hips and knees the Clinical Senate was asked to assist in recommending the optimum follow up process. The question arose due to the lack of current guidelines, the very varied practice and the rapidly growing numbers of people who require follow up. The work was undertaken to provide preliminary guidelines whilst further evidence emerges and the British Orthopaedic Association (BOA) considers issuing new guidelines.